SPARTANBURG, S.C. — In an effort to make reporting the dispensing of controlled substances easier for it pharmacy partners, QS/1 announced Monday that it had become the first pharmacy management software provider to offer integration with Apriss Health’s NARxCHECK. NARxCheck is a tool designed to fight prescription drug abuse by offering pharmacies real-time access to data collected by prescription drug monitoring programs.
QS/1’s integration facilitates the exchange of information between the pharmacy and Apriss Health to allow NARxCHECK to analyze a patient’s prescription profile against various PDMPs to determine whether a patient might be obtaining multiple prescriptions for controlled substances.
“It’s a unique exchange of information that can alert of possible overuse or abuse of prescription drugs,” South Carolina Pharmacy Association president Ed Vess said. “Rather than just filling the prescription and sending the information to the state PDMP, NARxCHECK shows the pharmacy staff all controlled substance prescriptions that the patient has been previously provided. It allows the pharmacist a chance to make an informed decision on whether they should fill the prescription, ask a few more questions, or refuse to fill the prescription.”
NARxCheck allows for the possibility for PMP data to be shared across state line if a patient is filling prescriptions in other states where information is exchanged with Apriss Health.
“This risk assessment is invaluable in the effort to reduce inappropriate access to opioids, improve patient safety and prevent addiction and abuse of prescription drugs,” Vess added.